Skip to content

Internet-Based Interventions for MDD

Effectiveness of Internet-Based Interventions for Treatment Compliance and Outcomes of Major Depressive Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04684277
Enrollment
440
Registered
2020-12-24
Start date
2021-09-01
Completion date
2023-06-30
Last updated
2021-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Medication Adherence

Brief summary

The acute and remission depression patients of 18-65 years old were recruited. At the time of enrollment, the demographic, symptomatic, neuropsychological and medication adherence data was collected. After the completion of the baseline assessment and examination, the patients were given antidepressant treatment or antidepressant treatment combined with Internet-based interventions. Clinical evaluation was performed at 1, 3 months (acute patients) and 6, 12 months (remission patients) after treatment, including the medication adherence, therapeutic efficacy, recurrence rate and functional rehabilitation. Through above work, this research is expected to provide clinicians with a set of Internet generalized technologies to improve the compliance and clinical outcomes of patients with depression, and to provide patients with treatment and management of the entire disease cycle.

Interventions

DRUGantidepressant treatment

depression recieve antidepressant treatment

OTHERantidepressant treatment combined with Internet-based interventions

depression recieve antidepressant treatment combined with Internet-based interventions

Sponsors

Peking University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-65 years old, acute (HAMD17 \> 17) and remission (HAMD17 \< 8) depression

Exclusion criteria

* other mental illnesses, serious somatic illnesses

Design outcomes

Primary

MeasureTime frameDescription
HAMD17 reduction ratio3 monthsThe difference of HAMD17 reduction ratio between the two groups was compared
recurrence rate12 monthsThe difference of recurrence rate between the two groups was compared

Countries

China

Contacts

Primary ContactYunai Su, MD
suyunai@163.com8610-62352880
Backup ContactJitao Li, MD
ljt_102124@163.com8610-82801960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026